Owing to their unique physiochemical property, the formulation of nanoparticles is extremely challenging, prompting drug developers to leverage the expertise of technology developers and service providers Roots Analysis has announced the addition of “Nanoparticle Formulation Technologies andRead more
Owing to their unique physiochemical property, the formulation of nanoparticles is extremely challenging, prompting drug developers to leverage the expertise of technology developers and service providers
Roots Analysis has announced the addition of “Nanoparticle Formulation Technologies and Services Market, 2023-2035” report to its list of offerings.
The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this market, across different geographies. Amongst other elements, the report includes:
- An executive summary of the insights captured during our research. It offers a high-level view on the current state of nanoparticle formulation market, including both technologies and services, and its likely evolution in the mid to long term.
- A general overview of the nanoparticles, highlighting the different types of nanoparticles, methods of nanoparticle formulation, challenges associated with formulation of nanoparticles and need for outsourcing such operations.
- A detailed assessment of the current technology landscape of nanoparticle formulations technologies, based on several relevant parameters.
- A comprehensive assessment of the overall service providers landscape of the companies offering nanoparticle formulation service, based on several relevant parameters.
- An insightful competitiveness analysis of nanoparticle formulation technologies developed by various stakeholders based in North America, Europe, and Asia-Pacific, Middle East and North Africa and Rest of the World.
- A detailed competitiveness analysis of nanoparticle formulation service providers.
- Elaborate profiles of prominent players developing technologies and offering services for nanoparticle formulation across North America, Europe and Asia-Pacific.
- A detailed analysis of the partnerships inked between stakeholders in nanoparticle formulation market, since 2018.
- An in-depth analysis of various patents that have been filed / granted related to nanoparticle formulation, since 2018.
- An insightful framework evaluating types of nanoparticles based on several relevant parameters.
- A case study of the recent technology licensing agreements, along with information on deal amounts.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Type of Nanoparticle Formulated
- Organic Nanoparticles
- Inorganic Nanoparticles
- Carbon-based Nanoparticles
- Type of Organic Nanoparticle Formulated
- Polymeric Nanoparticles
- Lipid Nanoparticles
- Viral Nanoparticles
- Protein-based Nanoparticles
- Other Organic Nanoparticles
- Scale of Operation
- Preclinical
- Clinical
- Commercial
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
- Latin America
Key companies covered in the report
- Ascension Sciences
- DIANT Pharma
- ExonanoRNA
- Nanoform
- NanoVation Therapeutics
- NanoVelos
- NTT Biopharma
- Organoid-X BioTech
- Vaxinano
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/nanoparticle-formulation-market.html
Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Novel Cell Cytometers: Need of the Hour
Learn from our recently published whitepaper: –
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting – the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
See less
Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings. Key Market Insights Presently, over 90 non-viral drug delivery systems developers are engaged in tRead more
Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings.
Key Market Insights
Table of Contents
1.1. Scope of the Report
1.2. Research Methodology
1.3. Market Segmentations
1.4. Key Questions Answered
1.5. Chapter Outlines
3.1. Chapter Overview
3.2. Need for Targeted Drug Delivery
3.3. Advanced Approaches for Delivery of Drug Payloads
3.4. Future Perspectives
4.1. Chapter Overview
4.2. Intracellular Drug Delivery: List of Technologies
4.3. Intracellular Drug Delivery: List of Technology Developers
5.1. Chapter Overview
5.2. Analysis by Type of Technology
5.3. Analysis by Company Size and Type of Molecule Delivered
5.4. Analysis by Location of Headquarters (Region-wise) and Type of Service Provider
5.5. Analysis by Company Size and Location of Headquarters
6.1. Chapter Overview
6.2. Assumptions / Key Parameters
6.3. Methodology
6.4. Company Competitiveness Analysis: Benchmarking of Portfolio Strength
6.5. Company Competitiveness Analysis: Benchmarking of Partnership Strength
7.1. Arcturus Therapeutics
7.2. Bio-Path
7.3. CureVac
7.4. Entos Pharmaceuticals
7.5. eTheRNA immunotherapies
7.6. Matinas BioPharma
7.7. MDimune
7.8. PCI Biotech
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Intracellular Drug Delivery Technologies: Patent Analysis
8.4. Intracellular Drug Delivery Technologies: Patent Valuation Analysis
9.1. Chapter Overview
9.2. Partnership Models
9.3. Intracellular Drug Delivery Technologies: List of Partnerships and Collaborations
10.1. Chapter Overview
10.2. Kalbach Innovation Model
10.3. Competitive Assessment Framework
10.4. BCG Matrix
11.1. Chapter Overview
11.2. Key Assumptions
11.3. Forecast Methodology
11.4. Global Non-Viral Intracellular Drug Delivery Technologies Market, 2022-2035
11.5. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Payment Model Employed, 2022 and 2035
11.6. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Molecule Delivered, 2022 and 2035
11.7. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Biologic Delivered, 2022 and 2035
11.8. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Technology, 2022 and 2035
11.9. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Target Therapeutic Areas, 2022 and 2035
11.10. Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Geography, 2022 and 2035
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html
News article
Modular Facility Manufacturers Market
Learn from experts: do you know about these emerging industry trends?
Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting – the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com